单宁酸在制备预防或治疗高脂饮食导致的肥胖和 / 或相关代谢紊乱的产品中的应用
Tannic acid addresses obesity and metabolic disorders caused by high-fat diets by improving gut microbiota structure and metabolic pathways, achieving significant anti-obesity, lipid-lowering, and metabolic improvement effects, and has the potential to be developed into drugs, functional foods, or dietary supplements.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BEIJING TECH & BUSINESS UNIV
- Filing Date
- 2026-05-15
- Publication Date
- 2026-07-17
AI Technical Summary
Obesity and related metabolic disorders caused by a high-fat diet, especially gut microbiota imbalance, intestinal barrier damage, and metabolic endotoxemia, lack effective regulatory means with current technology.
Tannic acid can be used to improve the structure of the gut microbiota by increasing the relative abundance of Bacteroidetes, decreasing the relative abundance of Firmicutes, regulating arachidonic acid, retinol and purine metabolism, repairing the intestinal barrier, reducing pro-inflammatory factors and restoring the integrity of the intestinal barrier.
It significantly inhibits weight gain, reduces lipid deposition, improves glucose and lipid metabolism, lowers serum inflammatory factors, restores gut microbiota diversity, corrects metabolite disorders, and has anti-obesity and lipid-lowering effects, while protecting liver function.
Smart Images
Figure CN122398827A_ABST